TrademarkDir
SOPHROSYNE PHARMACEUTICALS
LIVE

Serial Number

98447760

Owner

Sophrosyne Holdings LLC

Attorney

Aric S. Jacover

First Use Date

Feb 17, 2021

Filing Date

Mar 13, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SOPHROSYNE PHARMACEUTICALS Trademark

Serial Number: 98447760 • Registration: 7978019

SOPHROSYNE PHARMACEUTICALS is a trademark filed by Sophrosyne Holdings LLC on March 13, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Sophrosyne Holdings LLC (2 trademarks)

540 W Madison St., Suite 2500
Chicago, IL 60661

Entity Type: 16

SOPHROSYNE PHARMACEUTICALS INC.

540 W MADISON ST.
CHICAGO, IL 60661

Entity Type: 03

Trademark Details

Filing Date

March 13, 2024

Registration Date

October 7, 2025

First Use Anywhere

February 17, 2021

First Use in Commerce

February 17, 2021

Published for Opposition

October 29, 2024

Goods & Services

Research and development for FDA-approved prescription medications to address alcohol use disorder (AUD) and other addiction disorders, excluding nutritional supplements

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 21, 2026 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 7, 2025 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 3, 2025 NRCC
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 15, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 15, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 21, 2025 SUPC
USE AMENDMENT FILED
Jul 30, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 30, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 22, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 21, 2025 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jun 18, 2025 TPEX
NOTICE OF REVIVAL - E-MAILED
Jun 18, 2025 NREV
PETITION TO REVIVE-GRANTED
Jun 18, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 18, 2025 PROA
SOU EXTENSION 1 FILED
Jun 9, 2025 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 10, 2024 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 14, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2024 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 29, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2024 CNSA
ASSIGNED TO EXAMINER
Sep 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2024 NWOS
NEW APPLICATION ENTERED
Mar 15, 2024 NWAP

Related Trademarks

More from this Owner

SOPHROSYNE PHARMACEUTICALS

SOPHROSYNE PHARMACEUTICALS

SOPHROSYNE PHARMACEUTICALS

SOPHROSYNE PHARMACEUTICALS